Induced pluripotent stem cell technology: a decade of progress

被引：0
|
作者：
Yanhong Shi
Haruhisa Inoue
Joseph C. Wu
Shinya Yamanaka
机构：
[1] Beckman Research Institute of City of Hope,Division of Stem Cell Biology Research, Department of Developmental and Stem Cell Biology
[2] Center for iPS Cell Research and Application (CiRA),undefined
[3] Kyoto University,undefined
[4] Stanford Cardiovascular Institute,undefined
[5] Gladstone Institute of Cardiovascular Disease,undefined
来源：
Nature Reviews Drug Discovery | 2017年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Human induced pluripotent stem cell (iPSC) technology has evolved rapidly since its inception in 2007.Human iPSC technology has been widely used for disease modelling; for example, for neurodegenerative and psychiatric disorders.Human iPSC technology has yielded several drug candidates that are currently in clinical trials.The first clinical trial using human iPSC-derived products has been initiated for age-related macular degeneration.The combination with gene editing and 3D organoid technologies makes the iPSC platform more powerful.The continued development of iPSC technology and its integration with other technologies has the potential to make substantial contributions to disease modelling, drug discovery and regenerative medicine.
引用
收藏
页码：115 / 130
页数：15
相关论文
共 50 条
  • [31] Current progress and prospects of induced pluripotent stem cells
    CHEN LingYi & Liu Lin Key Laboratory of Bioactive Materials of Ministry of Education
    Science in China(Series C:Life Sciences), 2009, (07) : 622 - 636
  • [32] Current progress and prospects of induced pluripotent stem cells
    Chen LingYi
    Liu Lin
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2009, 52 (07): : 622 - 636
  • [33] Current progress and prospects of induced pluripotent stem cells
    LingYi Chen
    Lin Liu
    Science in China Series C: Life Sciences, 2009, 52 : 622 - 636
  • [34] Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise
    Duelen, Robin
    Sampaolesi, Maurilio
    EBIOMEDICINE, 2017, 16 : 30 - 40
  • [35] Brain tumors and induced pluripotent stem cell technology: a systematic review of the literature
    Shayestehfar, Monir
    Taherkhani, Tina
    Jahandideh, Pardis
    Hamidieh, Amir A.
    Faramarzpour, Mahsa
    Memari, Amirhossein
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (01): : 250 - 264
  • [36] The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
    Allan Acab
    Alysson Renato Muotri
    Neurotherapeutics, 2015, 12 : 534 - 545
  • [37] Progress toward establishing embryonic stem or induced pluripotent stem cell-based clinical translation
    Zavazava, Nicholas
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2014, 19 (06) : 598 - 602
  • [38] Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
    Elsayed, Ahmed K.
    Vimalraj, Selvaraj
    Nandakumar, Manjula
    Abdelalim, Essam M.
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (03): : 221 - 235
  • [39] The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
    Acab, Allan
    Muotri, Alysson Renato
    NEUROTHERAPEUTICS, 2015, 12 (03) : 534 - 545
  • [40] Induced Pluripotent Stem Cell Overview
    Chu, Vi
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (04): : 40 - +
12345